HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.

AuthorsAlissa Huston, Jason Brown, G David Roodman
JournalExperimental hematology (Exp Hematol) Vol. 34 Issue 12 Pg. 1616 (Dec 2006) ISSN: 0301-472X [Print] Netherlands
PMID17157156 (Publication Type: Case Reports, Letter)
Chemical References
  • Immunoglobulin A
  • Immunoglobulin lambda-Chains
  • Thalidomide
  • Dexamethasone
Topics
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Dexamethasone (adverse effects, therapeutic use)
  • Follow-Up Studies
  • Humans
  • Immunoglobulin A (blood)
  • Immunoglobulin lambda-Chains (blood, urine)
  • Male
  • Multiple Myeloma (complications, diagnosis, drug therapy)
  • Renal Insufficiency (etiology)
  • Thalidomide (adverse effects, therapeutic use)
  • Treatment Outcome
  • Tumor Lysis Syndrome (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: